The two largest players in lithium chemistry have both made significant investments in the past month, with Albemarle closing a deal that gives it a stake in a spodumene mine in Western Australia and Livent has begun construction of more lithium hydroxide production in the US.
Evonik and Siemens have launched their joint research project Rheticus II, which seeks to develop an efficient and powerful test plant that will develop speciality chemicals from CO2, water, renewable electricity and bacteria.
Azelis has agreed to acquire Ekin Kimya, a major Turkish distributor of speciality chemicals, pharmaceutical and lab chemicals and food ingredients, from Aktas Dıs Ticaret and individual shareholders.
Arkema has announced that it has brought a new 90,000 tonnes/year acrylic acid reactor at its site in Clear Lake, Texas, at a cost of about $90 million. This replaces two 45,000 tonnes/year reactors, which have been decommissioned.
Piedmont Lithium has said that it is accelerating the development of its lithium chemical plant in the Carolina Tin-Spodumene Belt, near Charlotte, which is claimed to be tone of the world’s best lithium sources.
The board of Innophos Holdings has unanimously agreed to be acquired by private equity firm One Rock Capital Partners. The $32/share deal equates to a transaction value of about $932 million, including debt.
Susan Miller, director of public relations at marketing agency 5MetaCom, looks at how chemicals companies should respond to different types of crisis.